Mifepristone (RU486) alone or in combination with a prostaglandin analogue for termination of early pregnancy: A review

58Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.

Abstract

The availability of a medical mode of termination of early pregnancy by the administration of RU486, an antiprogesterone alone, or in combination with one of the PG analogues significantly reduces the maternal morbidity and mortality associated with the classical surgical abortion. RU486 given alone in early pregnancy induces complete abortion in 60% to 85% of cases, and when combined with prostaglandin analogues, gemeprost or sulprostone, reaches a success rate of 95% to 99%. RU486 may also be of potential value in the medical treatment of ectopic pregnancy. Its use as a postcoital contraception is suggested, but further research is required to determine whether RU486 can be used on a once-a-month basis for contraception.

Cite

CITATION STYLE

APA

Avrech, O. M., Golan, A., Weinraub, Z., Bukovsky, I., & Caspi, E. (1991). Mifepristone (RU486) alone or in combination with a prostaglandin analogue for termination of early pregnancy: A review. Fertility and Sterility. https://doi.org/10.1016/S0015-0282(16)54527-0

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free